Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 2630-2637

  Cavanaugh, Victoria J ^a   Guidotti, Luca G ^a   Chisari, Francis V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; HEPATITIS B VIRUS; INTERFERON PRODUCTION; INTERSTITIAL NEPHRITIS; KIDNEY PROXIMAL TUBULE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS HEPATITIS; VIRUS INHIBITION;

EID: 0031924393     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.2630-2637.1998     Document Type: Article

References (61)

1. Alcami, A., and G. L. Smith. 1995. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J. Virol. 69:4633-4639.
2. Bancroft, G. J., G. R. Shellam, and J. E. Chalmer. 1981. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J. Immunol. 126: 988-994.
3. Bouley, D. M., S. Kanangat, W. Wire, and B. T. Rouse. 1995. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice. J. Immunol. 155:3964-3971.
4. Bukowski, J. F., B. A. Woda, and R. M. Welsh. 1984. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52: 119-128.
5. Cavanaugh, V. J., L. G. Guidotti, and F. V. Chisari. 1997. Interleukin-12 inhibits hepatitis B virus replication in HBV transgenic mice. J. Virol. 71: 3236-3243.
6. Chalmer, J. E., J. S. Mackenzie, and N. F. Stanley. 1977. Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J. Gen. Virol. 37:107-114.
7. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu Rev. Immunol. 13:29-60.
8. Davis, G. L., J. H. Hoofnagle, and J. G. Waggoner. 1984. Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon. J. Med. Virol. 14:141-147.
9. Engelhardt, J. F., Y. Yang, L. D. Stratford-Perricaudet, E. D. Allen, K. Kozarsky, M. Perricaudet, J. R. Yankaskas, and J. M. Wilson. 1993. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nat. Genet. 4:27-34.
10. Finke, D., U. G. Brinckmann, V. ter Meulen, and U. G. Liebert. 1995. Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J. Virol. 69:5469-5474.
11. Gooding, L. R. 1992. Virus proteins that counteract host immune defenses. Cell 71:5-7.
12. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
13. Gresser, I., M. G. Tovey, M. T. Bandu, C. Maury, and D. Brouty-Boye. 1976. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J. Exp. Med. 144:1305-1315.
14. Grundy (Chalmer), J. E., J. S. Mackenzie, and N. F. Stanley. 1981. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect. Immun. 32:277-286.
15. Grundy, J. E., J. D. Shanley, and P. D. Griffiths. 1987. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet ii:996-999.
16. Guidotti, L. G., P. Borrow, M. V. Hobbs, B. Matzke, I. Gresser, M. B. A. Oldstone, and F. V. Chisari. 1996. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. USA 93:4589-4594.
17. Guidotti, L. G., and F. V. Chisari. 1996. To kill or to cure: options in host defense against viral infection, p. 478-483. In R. Zinkernagel and B. Bloom (ed.), Current opinion in immunology. Current Biology, Ltd., London, England.
18. Guidotti, L. G., B. Matzke, and F. V. Chisari. 1997. Hepatitis B virus is cell cycle independent during liver regeneration in transgenic mice. J. Virol. 71: 4804-4808.
19. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
20. Guidotti, L. G., V. Martinez, Y. T. Loh, C. E. Rogler, and F. V. Chisari. 1994. Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice. J. Virol. 68:5469-5475.
21. Guidotti, L. G., B. Matzke, H. Schaller, and F. V. Chisari. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.
22. Gutch, M. J., and N. C. Reich. 1991. Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc. Natl. Acad. Sci. USA 88:7913-7917.
23. Heise, M. T., and H. W. Virgin IV. 1995. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69:904-909.
24. + T cells from young and old mice. J. Immunol. 150: 3602-3614.
25. Kalvakolanu, D. V. R., S. K. Bandyopadhyay, M. L. Harter, and G. C. Sen. 1991. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins; block in transcriptional complex formation. Proc. Natl. Acad. Sci. USA 88:7459-7463.
26. Kohonen-Corish, M. R. J., N. J. C. King, C. E. Woodhams, and I. A. Ramshaw. 1990. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-γ. Eur. J. Immunol. 20:157-161.
27. Koszinowski, U. H., M. Del Val, and M. J. Reddehase. 1990. Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Curr Top. Microbiol. Immunol. 154:189-220.
28. Kozarsky, K., and J. M. Wilson. 1993. Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 3:499-503.
29. Lucin, P., S. Jongic, M. Messerle, B. Polic, H. Hengel, and U. H. Koszinowski. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J. Gen. Virol. 75:101-110.
30. Lucin, P., I. Pavic, B. Polic, S. Jonjic, and U. H. Koszinowski. 1992. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol. 66:1977-1984.
31. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFN-αβ. and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746-4756.
32. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045-1056.
33. Pavic, I., B. Polic, I. Crnkovic, P. Lucin, S. Jonjic, and U. H. Koszinowski. 1993. Participation of endogenous tumour necrosis factor α in host resistance to cytomegalovirus infection. J. Gen. Virol. 74:2215-2223.
34. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94:6874-6879.
35. Reich, N., R. Pine, D. Levy, and J. E. Darnell, Jr. 1988. Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A products. J. Virol. 62:114-119.
36. Reynolds, R. P., R. J. Rahija, D. I. Schenkman, and C. B. Richter. 1993. Experimental murine cytomegalovirus infection in severe combined immunodeficient mice. Lab. Anim. Sci. 43:291-295.
37. Rossol-Voth, R., S. Rossol, K. H. Schütt, S. Corridori, W. de Cian, and D. Falke. 1991. In vivo protective effect of tumor necrosis factor α against experimental infection with herpes simplex virus type I. J. Gen. Virol. 72: 143-147.
38. Salazar-Mather, T. P., R. Ishikawa, and C. A. Biron. 1996. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J. Immunol. 157:3054-3064.
39. Sambhi, S. K., M. R. J. Kohonen-Corish, and I. A. Ramshaw. 1991. Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc. Natl. Acad. Sci. USA 88:4025-4029.
40. Schreiber, M., and G. McFadden. 1994. The myxoma virus TNF-receptor homologue (T2) inhibits tumor necrosis factor-α in a species-specific fashion. Virology 204:692-705.
41. Selgrade, M. K., J. G. Nedrud, A. M. Collier, and D. E. Gardner. 1981. Effects of cell source, mouse strain, and immunosuppressive treatment on production of virulent and attenuated murine cytomegalovirus. Infect. Immun. 33:840-847.
42. Shanley, J. D. 1984. Host genetic factors influence murine cytomegalovirus lung infection and interstitial pneumonitis. J. Gen. Virol. 65:2121-2128.
43. Shanley, J. D., L. Biczak, and S. J. Forman. 1993. Acute murine cytomegalovirus infection induces lethal hepatitis. J. Infect. Dis. 164:264-269.
44. Sheehan, K. C. F., N. H. Ruddle, and R. D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factor. J. Immunol. 142:3884-3893.
45. Sheen, I.-S., Y.-F. Liaw, D.-Y. Lin, and C.-M. Chu. 1994. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J. Infect. Dis. 170:1358-1361.
46. Shellam, G. R., J. E. Allan, J. M. Papadimitriou, and G. J. Bancroft. 1981. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl. Acad. Sci. USA 78:5104-5108.
47. Stratford-Perricaudet, L. D., M. Levrero, J. F. Chasse, M. Perricaudet, and P. Briand. 1990. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1:241-256.
48. Symons, J. A., A. Alcami, and G. L. Smith. 1995. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551-560.
49. + T cells promote the clearance of influenza virus from major histocompatibility complex class II -/-respiratory epithelium. J. Virol. 70:1288-1291.
50. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replicative-defective adenovirus vectors. Nat. Med. 2: 545-550.
51. van den Broek, M. F., U. Müller, S. Huang, M. Aguet, and R. M. Zinkernagel. 1995. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:4792-4796.
52. Wold, W. S. M., and L. R. Gooding. 1991. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1-8.
53. Wong, G. H. W., and D. V. Goeddel. 1986. Tumor necrosis factor α and β inhibit virus replication and synergize with interferons. Nature 323:819-822.
54. Yang, Y., H. C. J. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.
55. Yang, Y., Q. Li, H. C. J. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
56. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gönczöl, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
57. Yang, Y., S. E. Raper, J. A. Cohn, J. F. Englehardt, and J. M. Wilson. 1993. An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc. Natl. Acad. Sci. USA 90:4601-4605.
58. Yang, Y., Q. Su, and J. M. Wilson. 1996. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70:7209-7212.
59. + CTLs in vivo. J. Immunol. 155: 2564-2570.
60. Yang, Y., Z. Ziang, H. C. J. Ertl, and K. M. Wilson. 1995. Upregulation of class I major histocompatibility complex antigens by interferon γ is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:7257-7261.
61. Zhang, X., D. R. Hinton, D. J. Cua, S. A. Stohlman, and M. M. C. Lai. 1997. Expression of interferon-γ by a coronavinis defective-interfering RNA vector and its effect on viral replication, spread, and pathogenicity. Virology 233: 327-338.